Antihypertensive and hypolipidemic effect of milk fermented by specific Lactococcus lactis strains

Journal of Dairy Science

Volumn 96, Issue 7, 2013, Pages 4094-4099

  Rodriguez Figueroa J C ^a,b   Gonzalez Cordova A F ^a   Astiazaran Garcia H ^a   Hernandez Mendoza A ^a   Vallejo Cordoba, B ^a  

^a CENTRO DE INVESTIGACIÓN EN ALIMENTACIÓN Y DESARROLLO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE CHIHUAHUA   (Mexico)

Author keywords

Antihypertensive effect; Fermented milk; Hypolipidemic effect; Lactococcus lactis

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; LIPID; TRIACYLGLYCEROL;

ANIMAL; ARTICLE; BLOOD; BLOOD PRESSURE; CHEMISTRY; DAIRY PRODUCT; FERMENTATION; HYPERTENSION; LACTOCOCCUS LACTIS; MALE; METABOLISM; MICROBIOLOGY; MILK; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CULTURED MILK PRODUCTS; FERMENTATION; HYPERTENSION; HYPOLIPIDEMIC AGENTS; LACTOCOCCUS LACTIS; LIPIDS; MALE; MILK; RATS; RATS, INBRED SHR; TRIGLYCERIDES;

LACTOCOCCUS LACTIS; RATTUS;

EID: 84879317757     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2012-6014     Document Type: Article

References (31)

1. Ahmadi S.A., Boroumand M.A., Gohari-Moghaddam K., Tajik P., Dibaj S.M. The impact of low serum tryglyceride on LDL-cholesterol estimation. Arch. Iran Med 2008, 11:318-321.
2. Official Methods of Analysis of AOAC International 2000, AOAC International, AOAC International, Gaithersburg, MD. 17th.
3. Ayad E.H.E. Starter culture development for improving safety and quality of Domiati cheese. Food Microbiol 2009, 26:533-541.
4. Brown L.M., Hansen C.T., Huberty A.F. Traits of the metabolic syndrome alter corpulent obesity in LAN, SHR and DSS rats: Behavioral and metabolic interactions with adrenalectomy. Physiol. Behav 2011, 103:98-103.
5. Chobanian A.V., Bakris G., Black H., Cushman W., Green L., Izzo J., Jones D., Materson B., Oparil S., Wright J., Roccella E. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 2003, 289:2560-2572. The National High Blood Pressure Education Program Coordinating Committe.
6. CIOMS (Council for International Organizations of Medical Sciences). 1985. International guiding principles for biomedical research involving animals. http://cioms.ch/publications/guidelines/1985_texts_of_guidelines.htm.
7. Civantos B., Aleixandre A. Blood pressure and α-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca. Eur. J. Pharmacol 2004, 489:101-110.
8. Department of Health and Human Services. 2000. Public Health Service, Healthy People 2010, Vol. I. US Government Printing Office, Washington, DC.
9. Doggrell S.A., Brown L. Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc. Res 1998, 39:89-105.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285, 2486-2497.
11. Guan-Wen C., Jenn-Shou T., Bonnie Sun P. Purification of angiotensin I-converting enzyme inhibitory peptides and antihypertensive effect of milk produced by protease-facilitated lactic fermentation. Int. Dairy J 2007, 17:641-647.
12. Gutiérrez-Méndez N., Vallejo-Cordoba B., González-Córdova A.F., Nevárez-Moorillón G.V., Rivera-Chavira B. Evaluation of aroma generation of Lactococcus lactis with an electronic nose and sensory analysis. J. Dairy Sci 2008, 91:49-57.
13. Hugenholtz J. The lactic acid bacterium as a cell factory for food ingredient production. Int. Dairy J 2008, 18:466-475.
14. Jäkälä P., Jauhiainen T., Korpela R., Vapaatalo H. Milk protein-derived bioactive tripeptides Ile-Pro-Pro and Val-Pro-Pro protect endothelial function in vitro in hypertensive rats. J. Funct. Foods 2009, 1:266-273.
15. Jauhiainen T., Wuolle K., Vapaatalo H., Kerojoki O., Nurmela K., Lowrie C., Korpela R. Oral absorption, tissue distribution and excretion of a radiolabelled analog of a milk-derived antihypertensive peptide, Ile-Pro-Pro, in rats. Int. Dairy J 2007, 17:1216-1223.
16. Kawase M., Hashimoto H., Hosoda M., Morita H., Hosono A. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J. Dairy Sci 2000, 83:255-263.
17. Kimoto-Nira H., Mizumachi K., Nomura M., Kobayashi M., Fujita Y., Okamoto T., Suzuki I., Tsuji N.M., Kurisaki J.I., Ohmomo S. Lactococcus sp. as potential probiotic lactic acid bacteria. Jpn. Agric. Res. Q 2007, 41:181-189.
18. Korhonen H. Milk-derived bioactive peptides: From science to applications. J. Funct. Foods 2009, 1:177-187.
19. López-Fandiño R., Otte J., van Camp J. Physiological, chemical technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitoryactivity. Int. Dairy J 2006, 16:1277-1293.
20. Manso M., Miguel M., Even J., Hernández R., Aleixandre A., López-Fandiño R. Effect of the long-term intake of an egg white hydrolysate on the oxidative status and blood lipid profile of spontaneously hypertensive rats. Food Chem 2008, 109:361-367.
21. Muguerza B., Ramos M., Sánchez E., Manso M.A., Miguel M., Aleixandre A., Delgado M.A., Recio I. Antihypertensive activity of milk fermented by Enterococcus faecalis strains isolated from raw milk. Int. Dairy J 2006, 16:61-69.
22. Nurminen M.-L., Sipola M., Kaarto H., Pihlanto-Leppälä A., Piilola K., Korpela R., Tossavainen O., Korhonen H., Vapaatalo H. α-Lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 2000, 66:1535-1543.
23. Odamaki T., Yonezawa S., Sugahara H. A one step genotypic identification of Lactococcus lactis subspecies at the species/strain levels. Syst. Appl. Microbiol 2011, 34:429-434.
24. Pal S., Ellis V., Dhaliwal S. Effects of whey protein isolate on body composition, lipids, insulin and glucose in overweight and obese individuals. Br. J. Nutr 2010, 104:716-723.
25. Quirós A., Ramos M., Muguerza B., Delgado M., Miguel M., Aleixandre A., Recio I. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. Int. Dairy J 2007, 17:33-41.
26. Rodríguez-Figueroa, J. C., A. F. González-Córdoba, H. Astiazarán-García, and B. Vallejo-Cordoba. 2012a. Hypotensive and heart rate-lowering effects in rats receiving milk fermented by specific Lactococcus lactis strains. Br. J. Nutr. http://dx.doi.org/10.1017/S0007114512002115.
27. Rodríguez-Figueroa J.C., González-Córdoba A.F., Torres-Llanez M.J., García H.S., Vallejo-Cordoba B. Novel angiotensin I-converting enzyme inhibitory peptides produced in fermented milk by specific wild Lactococcus lactis strains. J. Dairy Sci 2012, 95:5536-5543. 10.3168/jds.2011-5186b.
28. Sipola M., Finckenberg P., Korpela R., Vapaatalo H., Nurminen M.-L. Effects of long-term intake of milk products on blood pressure in hypertensive rats. J. Dairy Res 2002, 69:103-111.
29. Tavares T., Contreras M.M., Amorim M., Pintado M., Recio I., Malcata F.X. Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: In vitro effect and stability to gastrointestinal enzymes. Peptides 2011, 32:1013-1019.
30. Tavares T., Sevilla M.A., Montero M.J., Carrón R., Malcata F.X. Acute effect of whey peptides upon blood pressure of hypertensive rats, and relationship with their angiotensin-converting enzyme inhibitory activity. Mol. Nutr. Food Res 2012, 56:316-324.
31. Turpeinen A.M., Kampu M., Rönnback M., Seppo L., Kautiainen H., Jauhiainen T., Vapaatalo H., Korpela R. Antihypertensive and cholesterol-lowering effects of a spread containing bioactive peptides IPP and VPP and plant sterols. J. Funct. Foods 2009, 1:260-265.